Camden Office Space

Camden Office SpaceWolf Commercial Real Estate is the leading Camden commercial real estate broker with expertise in representing Camden office space.

We are the go-to Camden commercial real estate broker that buyers, sellers, owners and tenants rely on for the highest quality of service in the Camden commercial real estate market.  At Wolf Commercial Real Estate, we provide clients and prospects with ongoing detailed information about office space in Camden to help them achieve their real estate goals.

The experienced team at our Camden commercial real estate brokerage firm also is well versed on the current New Jersey economic development incentive plans that provide tax credits and other incentives to business that build or redevelop in designated areas such as Camden.  The Grow New Jersey Assistance Program (Grow NJ) and the Economic Redevelopment and Growth Program (ERG) make the decision to invest in Camden commercial real estate more attractive than ever.

For owners planning to sell and/or lease their office space in Camden, Wolf Commercial Real Estate develops and customizes a defined marketing plan for each property.  As the foremost Camden commercial real estate brokerage firm, our highly effective marketing strategy successfully pairs buyers and tenants with your available Camden office space.

For companies and individuals in the market to buy or lease new office space in Camden, the team of professionals at our Camden commercial real estate brokerage firm will identify the Camden office space that best suits their needs.  The Camden commercial real estate experts at Wolf Commercial Real Estate work closely with clients to ensure that the sale or lease terms for their new office space in Camden complement their commercial real estate goals.

With the two key New Jersey economic development incentive plans now in effect — the Grow New Jersey Assistance Program (Grow NJ) and the Economic Redevelopment and Growth Program (ERG) — the time has never been better to invest in Camden commercial real estate.  Grow New Jersey Assistance Program (Grow NJ) offers tax credits of up to $5,000 per job per year and bonus credits of up to $3,000 per job per year to developers undertaking a wide range of projects in urban areas such as Camden.  The Economic Redevelopment and Growth Program (ERG) offers bonus awards as incentives for developers building certain types of projects in redevelopment areas.

For more information about Camden office space for sale or lease or for more information about New Jersey economic development incentive plans, please contact the team at Wolf Commercial Real Estate, the premier Camden commercial real estate broker.

Search Our Commercial Real Estate Listings

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Founding of YouTube A Short History

YouTube is one of the most influential platforms in modern media, but its origin story is surprisingly simple: a small team wanted an easier way to share video online. In the early 2000s, uploading and sending video files was slow, formats were inconsistent, and most websites weren’t built for smooth playback. YouTube’s founders focused on removing those barriers—making video sharing as easy as sending a link.

Who Founded YouTube?

YouTube was founded by three former PayPal employees: Chad Hurley, Steve Chen, and Jawed Karim. They combined product thinking, engineering skills, and a clear user goal: create a website where anyone could upload a video and watch it instantly in a browser.

  • Chad Hurley — product/design focus and early CEO role
  • Steve Chen — engineering and infrastructure
  • Jawed Karim — engineering and early concept support

The Problem YouTube Solved

At the time, sharing video often meant emailing huge files or dealing with complicated players and downloads. YouTube made video:

  1. Uploadable by non-experts (simple interface)
  2. Streamable in the browser (no special setup)
  3. Sharable through links and embedding on other sites

Early Growth and the First Video

YouTube launched publicly in 2005. One of the most famous early moments was the first uploaded video, “Me at the zoo,” featuring co-founder Jawed Karim. The clip was short and casual—exactly the kind of everyday content that proved the platform’s big idea: ordinary people could publish video without needing a studio.

Key Milestones Timeline

Year/Date
Milestone
Why It Mattered
2005 YouTube is founded and launches Introduced easy browser-based video sharing
2005 “Me at the zoo” is uploaded Became a symbol of user-generated video culture
2006 Google acquires YouTube Provided resources to scale hosting and global reach

Why Google Bought YouTube

By 2006, YouTube’s traffic was exploding. Video hosting is expensive—bandwidth and storage costs rise fast when millions of people watch content daily. Google’s acquisition gave YouTube the infrastructure and advertising ecosystem to grow into a sustainable business.

What YouTube’s Founding Changed

YouTube didn’t just create a popular website; it reshaped how people learn, entertain themselves, and build careers online. Its founding helped accelerate:

  • Creator-driven media and influencer culture
  • How-to education and free tutorials at massive scale
  • Music discovery, commentary, and global community trends

From a small startup idea to a global video powerhouse, YouTube’s founding is a classic example of a simple product solving a real problem—and changing the internet in the process.

Camden County Acquires Site for Planned 25-Story Beacon Office Tower

Camden County Acquires Site for Planned 25-Story Beacon Office Tower

The Camden County Improvement Authority purchased a development site in Camden for $4.7 million. The acquisition advances plans for the proposed Beacon Building project.

The property at 540-552 Federal Street was purchased from the Parking Authority of Camden City. The site currently operates as a surface parking lot between Federal Street and Martin Luther King Jr. Boulevard.

Developers plan a 25-story, 500,000-square-foot office tower at the location. Notably, the Beacon Building would become the largest office building in South Jersey.

However, construction remains several years away. First, the property will operate as a temporary transportation center.

The temporary facility will support two dozen bus lines. Meanwhile, the nearby Walter Rand Transportation Center will undergo a $250 million redevelopment.

Camden County expects construction on the transit hub renovation to begin later this year. Officials recently issued a request for proposals for an owner’s representative.

Funding for the transportation center project is already in place through the state. Once the project finishes, development of the Beacon Building could move forward.

County officials remain optimistic about the timeline. Early planning work has continued since the project was announced in January 2025.

*Article courtesy of Philadelphia Business Journal

For more information about Camden office space for sale or lease or about any other properties, please contact WCRE at 856-857-6300.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier Camden commercial real estate broker that provides a full range of commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other commercial properties for buyers, tenants, investors and sellers.

Please visit our website, www.wolfcre.com, for a full listing of Camden commercial properties for lease or sale.

Camden’s Beacon: A Bold Office Tower on the Horizon

Camden Skyline Changing

Camden officials are quietly advancing plans for a new 25-story office tower that would transform the city’s skyline and become South Jersey’s tallest commercial building. Proposed for the parking lot near Federal Street and Broadway, the project—known as The Beacon Building—would deliver roughly 500,000 square feet of Class A office space adjacent to the Walter Rand Transportation Center.

The development team, led by the Camden County Improvement Authority, is navigating key steps including site ownership, tenant commitments, and securing Aspire state tax credits. Early interest from major players like Cooper University Health Care, Rutgers University, and the state judiciary could fill nearly half the tower, helping attract financing and additional tenants.

Officials say the project represents a bold statement for Camden’s ongoing revitalization—combining prime transit access with modern design to create a landmark destination for business and community growth.

*Article courtesy of RE-NJ

For more information about Camden office space for sale or lease or about any other properties, please contact WCRE at 856-857-6300.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier Camden commercial real estate broker that provides a full range of commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other commercial properties for buyers, tenants, investors and sellers.

Please visit our website, www.wolfcre.com, for a full listing of Camden commercial properties for lease or sale.

25-Story Office Building Planned for Rand Transportation Center in Camden

Camden Office Building Redevelopment
A 25-story office building is being proposed for downtown Camden as part of the redevelopment of the Walter Rand Transportation Center, according to an announcement from Camden County and NJ Transit scheduled for Tuesday.

Known as the Beacon Building, the structure would become the largest office building in South Jersey outside Atlantic City. The $250 million transportation center, located at Federal Street and Broadway, is currently in the design phase.

Jeffrey Nash, CEO of the Rowan University/Rutgers-Camden Joint Board of Directors, stated during a September press conference that the complete redevelopment of the site could result in a $1 billion investment.

*Article courtesy of TapInto

For more information about Camden office space for sale or lease or about any other properties, please contact WCRE at 856-857-6300.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier Camden commercial real estate broker that provides a full range of commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other commercial properties for buyers, tenants, investors and sellers.

Please visit our website, www.wolfcre.com, for a full listing of Camden commercial properties for lease or sale.

Camden Leaders Advertise Opportunities for Developers

Camden Leaders Advertise Opportunities for Developers

On Thursday, regional business executives received real estate pitches from local leaders, highlighting government-owned properties available for sale and development in Camden.

The meeting of the New Jersey Alliance for Action, a nonprofit organization that promotes the state’s economy, featured Camden’s community leaders presenting several of the city’s success stories and plans for new construction.

Camden Mayor Victor Carstarphen and Louis Cappelli Jr., director of the Camden County Board of Commissioners, urged the audience at the Salvation Army Kroc Center to consider investing in developments in the city.

*Article courtesy of TapintoCamden

For more information about Camden office space for sale or lease in Camden or about any other Camden  properties for sale or lease, please contact WCRE at 856-857-6300.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier  Camden commercial real estate broker that provides a full range of Camden commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other  Camden commercial properties for buyers, tenants, investors and sellers.

Please visit our websites for a full listing of Camden commercial properties for lease or sale through our  Camden commercial real estate brokerage firm.